Analysis of residual content of used syringes collected from low threshold facilities in Lausanne, Switzerland.

[1]  P. Esseiva,et al.  The cutting of cocaine and heroin: A critical review. , 2016, Forensic science international.

[2]  P. Esseiva,et al.  Qualitative, quantitative and temporal study of cutting agents for cocaine and heroin over 9 years. , 2015, Forensic science international.

[3]  Y. Lévi,et al.  Drug analysis of residual content of used syringes: a new approach for improving knowledge of injected drugs and drug user practices. , 2015, The International journal on drug policy.

[4]  M. Vogel,et al.  Treatment or "high": benzodiazepine use in patients on injectable heroin or oral opioids. , 2013, Addictive behaviors.

[5]  R. Sedefov,et al.  Misuse of Medicines in the European Union: A Systematic Review of the Literature , 2012, European Addiction Research.

[6]  A. Jeannin,et al.  Trends in drug consumption and risk of transmission of HIV and hepatitis C virus among injecting drug users in Switzerland, 1993-2006. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[7]  M. Soyka,et al.  Co-Consumption of Benzodiazepines in Heroin Users, Methadone-Substituted and Codeine-Substituted Patients , 2006, Journal of addictive diseases.

[8]  M. Lynskey,et al.  Health service utilization and benzodiazepine use among heroin users: findings from the Australian Treatment Outcome Study (ATOS). , 2003, Addiction.

[9]  R. Bruno,et al.  Recent trends in benzodiazepine use by injecting drug users in Victoria and Tasmania. , 2002, Drug and alcohol review.

[10]  W. Hall,et al.  Heroin overdose: causes and consequences. , 2001, Addiction.

[11]  W. Hall,et al.  Benzodiazepine use among heroin users in Sydney: patterns of use, availability and procurement. , 1996, Drug and alcohol review.

[12]  J. Drozd.  Chemical Derivatization in Gas Chromatography , 1981 .

[13]  F. Dubois-Arber,et al.  Résultats de l'enquête 2011 auprès des usagers des structures à bas-seuil en Suisse , 2012 .

[14]  A. Jeannin,et al.  A high proportion of users of low-threshold facilities with needle exchange programmes in Switzerland are currently on methadone treatment: implications for new approaches in harm reduction and care. , 2012, The International journal on drug policy.

[15]  P. Morency,et al.  Global evaluation of the Confederation's measures to reduce drug-related problems (ProMeDro) : fourth synthesis report 1999-2002 , 2003 .